Verona jumps after report on Merck nearing $10 billion acquisition

Verona Pharma

09/07/2025 09:41

** U.S.-listed shares of Verona Pharma VRNA.O I9SAy.F rise 18.8% to $103.16 premarket

** Merck MRK.N is nearing a deal worth about $10 billion to buy Verona, Financial Times reports

** Merck will pay $107 per American depository share for Verona, the report says, citing three people familiar with the matter

** The reported purchase price will be at a premium of about 23% to Verona ADS' last close

** Up to last close, stock up 87% YTD

(Reporting by Christy Santhosh)

((Christy.Santhosh@thomsonreuters.com))